A 26-year-old man, diagnosed with acute myelogenous leukemia had multiple inflammatory pseudotumors (IPT) in the liver. The patient presented complete remission after remission induction therapy, and then showed right upper quadrant discomfort and intermittent
Introduction
An inflammatory pseudotumor (IPT) is a rare fibro-inflammatory lesion of unknown origin (1) . IPT in the liver usually appears as a solitary mass. Multiple IPTs are rare (2, 3) . Multiple IPTs are often confused with metastasis or abscess, when associated with malignant diseases and treatment with cytotoxic agents. Recently, reports of hepatic candidiasis have increased in cases of blood disorders (4). It is difficult to distinguish between multiple IPTs and hepatic candidiasis. This study presents the follow-up imaging appearance of multiple IPTs of the liver in an acute myelogenous leukemia (AML) patient. Moreover, with a repeat liver biopsy, it shows a correlation between the radiographic changes ofIPT and histopathologic findings.
Case Report
A 26-year-old man developed headache and fever in May 1996. Laboratory findings are listed in Table 1 . They revealed a white blood cell count of 1,800/mm3 with 32% myeloblasts. Myelogram demonstrated the excess of myeloblasts and the patient as AML, M2 on the French-American-British classification. Chromosomal analysis of bone marrow cells revealed translocation(8 ;2 1 )(q22;q22). Three positive signals were identified in 75% of bone marrow cells by fluorescent in situ hybridization. The patient received chemotherapy, according to the Japan-Adult-Leukemia-Study Group 87 protocol (BHAC-DMP: enocitabine, daunorubicin, 6-mercaptopurine riboside, and prednisolone).
He developed remission with no sepsis after the second remission induction therapy. A repeat bone marrow examination at the termination of chemotherapy showed no leukemiacells. Before the consolidation therapy, the patient began to notice dull right upper quadrant discomfort and intermittent fever. Laboratory tests revealed an elevation of the serum C-reactive protein (CRP) level from 0.8 to 8.7 mg/dl and an increase in alkaline phosphatase (ALP) level from 56 to 138 IU (normal 39-125). The bilirubin and lactate dehydrogenase (LDH) were in the normal range.
Anultrasonography disclosed multiple hypoechoic nodules of up to 3 cm in the liver. A computed tomography (CT) scan showed multiple low-density masses, which were weakly isoenhanced with contrast media (Fig. 1) . Magnetic resonance (MR) imaging was performed. On both Tl-weighted and T2-weighted images, several nodules were hyperintense relative to the liver. Other nodules demonstrated central hyperintensity on Tl-and T2-weighted imagings with peripheral hypointensity on the Tl-weighted image ( Fig. 2) . A needle biopsy of the nodules was performed twice with ultrasonography. Histological examination showed focal liver cell necrosis with mild fibrosis and scant inflammatory cells (Fig. 3) During the following months, the patient received consolidation chemotherapy, and remained asymptomatic. Follow-up CT scans at the termination of chemotherapy revealed an increase in the number and change in the pattern of contrast enhancement in the hepatic nodules.
The delayed-phase CT scan showed an enhancement at the periphery of several nodules (Fig. 4) . A second liver biopsy was again performed on the same nodule at the initial biopsy. A specimen showed concentrated fibrosis and focal liver cell necrosis surrounded by epithelioid like cells (Fig. 5) . The moderate infiltration of neutrophils, eosinophils, and lymphocytes was shown. The follow-up CT 10 months after the initial study revealed markedly smaller nodules with fine calcifications.
The patient remains complete remission.
Discussion
IPT of the liver may be a rare benign process characterized by chronic inflammation rather than a single disease entity. IPT usually appears as a solitary mass, and rarely as multiple nodules (3, 5). Multiple IPTs should be distinguished from metastasis and abscess. In the present case, multiple nodules of the liver were initially suspected to be an abscess or metastasis because of the patient' s antileukemia chemotherapy for AML. We performed a liver biopsy, and showed the specimen to have a characteristic appearance of IPT. Therefore, we wish to emphasize the importance of a liver biopsy in the differential diagnosis of multiple liver nodules, especially when associated with malignant diseases. Moreover, a follow-up liver biopsy may correlate dynamic changes in radiologic appearance with histopathologic findings. This case represents the first case to be reported in the literature of multiple IPTs associated with AML. IPT is described as a hypodense lesion with no significant change after the injection of an intravenous contrast medium on CT scans (6). In our case, ultrasonography demonstrated multiple low echoic nodules, and the initial CT scan showed weak, early enhancing nodules. The follow-up CT scans demonstrated a delayed higher enhancement at the periphery in several nodules. This change in the enhancement pattern on follow-up CT scans may be attributed to the particular stage of dynamic inflammatory process. Pathologically, the initial liver biopsy specimen showed a predominantly focal liver cell necrosis with mild cellular infiltration, and the second one consisted of concentrated fibrosis along with cellular infiltration. This pathologic change may explain the delayed enhancement of IPT on follow-up CT scans. Indeed, delayed enhancement has been reported in IPT with the area of fibrosis (7). IPT appeared homogenous or hypointense relative to the adjacent hepatic parenchyma on Tl-weighted MRI, and isointense or slightly hyperintense on T2-weighted MRI (6). In our case, several nodules demonstrated central enhancement on Tl-and T2-weighted imagings with peripheral hypointensity on Tl-weighted MRI. These MR imagings may show a central hemorrhage in several nodules. The differential diagnosis should encompass liver abscess, metastasis, and hepatocellular carcinoma. A liver abscess is an inflammatory liver disease, with symptoms and laboratory data similar to those of IPT. A typical liver abscess is characterized by a liquefactive necrosis of neutrophils, plasma cells, and histiocytes. Therefore, CT scans of a typical liver abscess show central water density. However, an atypical liver abscess with incomplete liquefaction may mimic IPT on CT scans, and thus may be difficult to differentiate from IPT. Metastatic tumors with fibrosis can show delayed enhancement on a CT scan. On the basis of CT findings alone, hepatic metastasis may also be difficult to distinguish from IPT. In our case, multiple low echoic nodules were found, and suspected to be metastasis or multiple liver abscess. However, these nodules were not compatible with CT findings of a typical liver abscess or metastatic nodules. Radiologic findings of IPT have been known to be nonspecific, and combined judgment is required.
The pathogenesis ofIPT remains unclear. In some cases, IPT has had possible antecedent factors, including trauma and infections (8). IPT may reflect a nonspecific inflammatory process of these factors. In our case, IPT appeared when the patient entered complete remission and recovered after the second remission induction chemotherapy. Several courses of antileukemia chemotherapy increased the number of hepatic nodules. We identified histologically no organisms in the biopsy specimen, and nothing was cultured. The antibiotic therapy evidenced no changes in the hepatic nodules. These results may suggest no direct linkage of microorganisms to IPT in this patient. The initial biopsy specimen showed small focal liver cell necrosis with no prominent inflammatory cells, a histological feature which may mimic drug-induced hepatitis. In our case, IPT may be attributable to the chemotherapy, which could trigger and affect the immunological responses of the host. The recognition of this form of IPT with AML is important for clinicians and radiologists to avoid inappropriate antileukemia and antibiotic chemotherapy.
